Celso Costa da Silva Júnior

Ms. Celso Costa da Silva Júnior

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 October 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
CJCelso Costa da Silva Júnior
Celso Costa da Silva Júnior
DQDayanna Joyce Marques Queiroz
Dayanna Joyce Marques Queiroz
MPMaria Paula de Paiva
Maria Paula de Paiva
MLMarina Travassos Lopes
Marina Travassos Lopes
MCManoel da Cunha Costa
Manoel da Cunha Costa
MGMaria da Conceição Rodrigues Gonçalves
Maria da Conceição Rodrigues Gonçalves


17 November 2023 in Metabolomics
Verified
Journal Article
Open access
PDF file
CSCássia Surama Oliveira Da Silva
Cássia Surama Oliveira Da Silva
MMMussara Gomes Cavalcanti Alves Monteiro
Mussara Gomes Cavalcanti Alves Monteiro
CFCarla Fechine
Carla Fechine
JTJosean Tavares
Josean Tavares
ASAugusto Souto
Augusto Souto
MCMaria José de Carvalho Costa
Maria José de Carvalho Costa
Introduction The prevalence of hypertension and obesity are a worldwide concern. Objetives Assess the metabolites profile after intervention with mixed dietary fiber in overweight and obese normotensive women. Methods This is a randomized double blind placebo-controlled study. Through a simple randomization process, two groups were allocated, with eleven women (group 1) receiving 12 g of mixed dietary fiber and thirteen women (group 2) receiving 12 g of placebo (corn starch) for eight weeks. Anthropometric and biochemical tests and lifestyle were analyzed. As for evaluation metabolomics, used a 1H NMR. The data matrix generated 96 samples and 225 variables, which was exported in the ASCII format for the “The Unscrumbler” statistics software (version 9.7, CAMO Process). Results After the intervention with mixed dietary fiber, significant differences were observed between the main types of metabolites, referring to the increase in the relative peak areas of in three HDL metabolites 4.94 ppm (0.0086*), HDL 1.28 ppm (0 .0337*), HDL 0.88 ppm (0.0224*) and an α-glucose metabolite 4.90 ppm (0.0106) and the reduction in systolic blood pressure (SBP) (0.0292*) of 7 mmHg in the reference range and in the placebo group there was a reduction in SBP (0.0118*) of 4 mmHg and of a choline metabolite 3.65 ppm (0.0266*), which does not call into question the validity of these results in the literature. Conclusion The synergism of the functions of these statistically highlighted metabolites contributed to prevention the increase in SBP after fiber intervention in overweight and obese normotensive women.

20 October 2021
Verified
Preprint
Open access
PDF file
DQDayanna Queiroz
Dayanna Queiroz
ASAlexandre Silva
Alexandre Silva
CJCelso Costa da Silva Júnior
Celso Costa da Silva Júnior
DPDarlene Persuh
Darlene Persuh
ADAlcides Diniz
Alcides Diniz
MRMateus Ribeiro
Mateus Ribeiro
Introduction: Cystic Fibrosis is a disease that causes inflammation, oxidative stress and metabolic changes that lead to nutrient deficiency, such as vitamin D. On the other hand, it is suggested that vitamin D has anti-inflammatory and antioxidant action. Objective: To evaluate the prevalence of hypovitaminosis D and the association between serum 25 hydroxyvitamin D levels with markers of oxidative stress and inflammation in patients with cystic fibrosis. Method: Cross-sectional study carried out with 48 patients with Cystic Fibrosis in children, adolescents and adults in the Northeast region/Brazil. Blood collection was performed for analysis of 25-hydroxyvitamin D, calcium, parathyroid hormone, inflammatory process (C-reactive protein -PCR and alpha-1-acid glycoprotein-A1-A1GPA) and oxidative stress (malondialdehyde-MDA and total antioxidant capacity-CAOT. Statistical analysis was performed using the “Statistical Pacage for the Social Sciences”, adopting a significance level of p<0.05. Results: Insufficiency/deficiency of D was found in 64.6% of patients. After multiple linear regression analysis, MDA showed an inverse association with blood values of 25-Hydroxyvitamin D (p < 0.05) Results: Insufficiency/deficiency of D was found in 64.6% of patients. After multiple linear regression analysis, MDA showed an inverse association with blood values of 25-Hydroxyvitamin D (p < 0.05) conditioned on the presence of inflammatory process markers. When only oxidative stress is evaluated, this association disappears. Conclusion: In conclusion, there was a high prevalence of hypovitaminosis D, with 25 (OHD) levels associated with greater oxidative stress when combined with inflammatory markers. Improved vitamin D levels may be an alternative to reduce the damage caused by excess oxidative stress and inflammation in CF patients.